QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (108) Citing Articles via Google Scholar Google Scholar Articles by Byrnes, A. P. Articles by Charlton, H. M. Search for Related Content PubMed PubMed Citation Articles by Byrnes, A. P. Articles by Charlton, H. M.

 Previous Article  |  Next Article 

Volume 16, Number 9, Issue of May 1, 1996 pp. 3045-3055
Copyright ©1996 Society for Neuroscience

Immunological Instability of Persistent Adenovirus Vectors in the Brain: Peripheral Exposure to Vector Leads to Renewed Inflammation, Reduced Gene Expression, and Demyelination

Received Dec. 14, 1995; revised Feb. 6, 1996; accepted Feb. 13, 1996.

Andrew P. Byrnes, Robert E. MacLaren, and Harry M. Charlton

Department of Human Anatomy, University of Oxford, Oxford OX1 3QX, United Kingdom

Nonreplicating adenovirus vectors are being developed as vehicles for the delivery of therapeutic genes in vivo. Whereas in many organs an antiviral T cell response eliminates the vector and damages local tissue, when adenovirus vectors are injected into the brain the subsequent immune attack can be ineffective, allowing the vector to persist.

In the present study, E1-deleted human adenovirus vectors were injected into the caudate nucleus of rats. Two months later, expression of protein from the vector was still evident and little inflammation was seen. A subcutaneous injection of adenovirus vector at this time, however, led within 2 weeks to severe mononuclear inflammation and microglial activation in the caudate. This caused local demyelination and a decrease in detectable protein expression from the vector. Interestingly, intense microglial activation and numerous lymphocytes and monocytes were also seen in brain areas containing neurons capable of retrogradely transporting the adenovirus vector from the caudate. Control experiments established that this inflammation in distant brain areas was not a nonspecific consequence of degeneration.

These experiments demonstrate that although adenovirus vectors can persist in the brain without causing chronic inflammation, they remain the potential target of a damaging cell-mediated immune response brought about by a subsequent peripheral exposure to vector. The finding of lymphocytes in brain areas that project to the caudate further shows that viral antigens that are retrogradely transported by neurons can also be the target of a T cell attack.

Key words: adenovirus; neuroimmunology; gene therapy; viral vector; demyelination; microglia; caudate

This article has been cited by other articles:

				J. M. Zirger, C. Barcia, C. Liu, M. Puntel, N. Mitchell, I. Campbell, M. Castro, and P. R. Lowenstein Rapid Upregulation of Interferon-Regulated and Chemokine mRNAs upon Injection of 108 International Units, but Not Lower Doses, of Adenoviral Vectors into the Brain. J. Virol., June 1, 2006; 80(11): 5655 - 5659. [Abstract] [Full Text] [PDF]

				L. Barzon, M. Boscaro, and G. Palu Endocrine Aspects of Cancer Gene Therapy Endocr. Rev., February 1, 2004; 25(1): 1 - 44. [Abstract] [Full Text] [PDF]

				M. Simons, R. O. Bonow, N. A. Chronos, D. J. Cohen, F. J. Giordano, H. K. Hammond, R. J. Laham, W. Li, M. Pike, F. W. Sellke, et al. Clinical Trials in Coronary Angiogenesis: Issues, Problems, Consensus : An Expert Panel Summary Circulation, September 12, 2000; 102 (11): e73 - e86. [Abstract] [Full Text] [PDF]

				C. E. Thomas, G. Schiedner, S. Kochanek, M. G. Castro, and P. R. Löwenstein Peripheral infection with adenovirus causes unexpected long-term brain inflammation in animals injected intracranially with first-generation, but not with high-capacity, adenovirus vectors: Toward realistic long-term neurological gene therapy for chronic diseases PNAS, June 6, 2000; (2000) 120474397. [Abstract] [Full Text]

				C. S. Stein, A. Ghodsi, T. Derksen, and B. L. Davidson Systemic and Central Nervous System Correction of Lysosomal Storage in Mucopolysaccharidosis Type VII Mice J. Virol., April 1, 1999; 73(4): 3424 - 3429. [Abstract] [Full Text]

				T. Cartmell, T. Southgate, G. S. Rees, M. G. Castro, P. R. Lowenstein, and G. N. Luheshi Interleukin-1 Mediates a Rapid Inflammatory Response After Injection of Adenoviral Vectors into the Brain J. Neurosci., February 15, 1999; 19(4): 1517 - 1523. [Abstract] [Full Text] [PDF]

				A. Bilang-Bleuel, F. Revah, P. Colin, I. Locquet, J.-J. Robert, J. Mallet, and P. Horellou Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease PNAS, August 5, 1997; 94(16): 8818 - 8823. [Abstract] [Full Text] [PDF]

				C. E. Thomas, G. Schiedner, S. Kochanek, M. G. Castro, and P. R. Lowenstein Peripheral infection with adenovirus causes unexpected long-term brain inflammation in animals injected intracranially with first-generation, but not with high-capacity, adenovirus vectors: Toward realistic long-term neurological gene therapy for chronic diseases PNAS, June 20, 2000; 97(13): 7482 - 7487. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help